Journal articleSci Transl Med2019
Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies.
- Journal
- Sci Transl Med
- Published
- 1 July 2019
- Citations
- 168
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 7
- Defining the barriers to immune surveillance in solid tumors F99CA223043↗
- Defining the barriers to immune surveillance in solid tumors K00CA223043↗
- 11 Solid Tumor Therapeutics Program P30CA091842↗
- Project 1: Overcoming Tumor-Induced Immune Suppression to Improve Responses to Immunotherapy P50CA196510↗
- The Impact of Macrophage Origin on the Pathogenesis and Treatment Resistance of Pancreatic Cancer R01CA177670↗
- COMBINED TUMOR AND STROMAL TARGETING TO IMPROVE PANCREATIC CANCER RESPONSE TO IMMUNOTHERAPY R01CA203890↗
- Exploiting Integrin Signaling to Overcome Resistance to Immunotherapy R01CA244938↗